Markus Rose

Dr. Markus Rose


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2012 in Journal of Veterinary Pharmacology and Therapeutics
Verified
Journal Article
Closed access
PDF file
MRMarkus Rose
Markus Rose
MMM. Menge
M. Menge
CBC. Bohland
C. Bohland
EZE. Zschiesche
E. Zschiesche
CWC. Wilhelm
C. Wilhelm
MNM. Nürnberger
M. Nürnberger

28 May 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
RTRobin Temmerman
Robin Temmerman
HBHelena Berlamont
Helena Berlamont
FGFarid El Garch
Farid El Garch
MRMarkus Rose
Markus Rose
SSShabbir Simjee
Shabbir Simjee
AJAnno de Jong
Anno de Jong
Bacterial urinary tract infections (UTIs) occur frequently in companion animals and are often treated with antibiotics. However, antimicrobial resistance can severely hamper treatment success. Therefore, antimicrobial susceptibility monitoring is key. UTI isolates were obtained from dogs and cats in two collection periods (ComPath II: 2013–2014 and ComPath III: 2017–2018) as part of CEESA’s ComPath programme. Susceptibility testing of the UTI isolates (2021 in total) was carried out at one central laboratory using agar and broth dilution methodology as recommended by the Clinical and Laboratory Standards Institute. Escherichia coli was the most frequently isolated bacterium in UTI in both dogs (46.9%, 43.1%) and cats (61.2%, 48.3%) across ComPath II and ComPath III, respectively. The percentage of resistance in E. coli was low (<10%) across both programmes in both dogs and cats except for trimethoprim-sulfamethoxazole (dogs ComPath III: 12.9%; cats ComPath II: 13.0%) and enrofloxacin (10.5%), marbofloxacin (11.4%), and doxycycline (98.8%) for dogs in ComPath III. Three (7.5%) of the 40 isolated S. aureus bacteria in total were MRSA and harboured mecA. The level of multidrug resistance (MDR) was generally low and ranged from 0.0% for feline coagulase-negative Staphylococcus spp. to 11.7% for canine Proteus spp., except for a peak of MDR observed in canine Klebsiella isolates from ComPath II (36.7%). Overall, antimicrobial resistance for most canine and feline UTI pathogens isolated during the ComPath II and ComPath III programmes was low (1–10%) to moderate (10–20%).

5 November 2015 in Journal of Veterinary Pharmacology and Therapeutics
Verified
Journal Article
Closed access
PDF file
MRMarkus Rose
Markus Rose
APA. Pridmore
A. Pridmore
ASA. Shaw
A. Shaw
CWC. Wilhelm
C. Wilhelm
MMM. Menge
M. Menge
MNM. Nürnberger
M. Nürnberger